Publication | Closed Access

Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy

OncologyMedicineMetronomic TherapyClinical PharmacologyPharmacotherapyMetronomic ChemotherapyDrug TherapyPharmacologyCancer ChemotherapyMultiple-day Chemotherapy